SCHEMBL6329481

SCHEMBL6329481

CCOC(=O)c1coc(-c2ccc(NC(=O)Nc3nnc(-c4cc(Cl)cc(Cl)c4O)s3)cc2)c1C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 6/20 0.42
KMT2A Q03164 6/20 0.42
RAB9A P51151 5/20 0.42
HTT P42858 5/20 0.42
SMN1; SMN2 Q16637 5/20 0.42
MAPT P10636 4/20 0.42
HPGD P15428 4/20 0.42
ALDH1A1 P00352 3/20 0.42
NPC1 O15118 3/20 0.42
GAA P10253 2/20 0.42
BLM P54132 4/20 0.40
POLB P06746 3/20 0.40
MCL1 Q07820 3/20 0.39
KDM4E B2RXH2 2/20 0.39
LMNA P02545 2/20 0.39
NPSR1 Q6W5P4 1/20 0.39
HPN P05981 1/20 0.39
DDX3X O00571 1/20 0.39
ACR P10323 1/20 0.38
DNMT1 P26358 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6322386 0.84 TRPV1 (0.53) MEN1KMT2ARAB9AHTTSMN1; SMN2
SCHEMBL6325807 0.81 TRPV1 (0.51) MEN1KMT2ARAB9AHTTSMN1; SMN2
SCHEMBL6448552 0.76 ACR (0.44) MEN1KMT2ARAB9ASMN1; SMN2MAPT
SCHEMBL6324529 0.76 MAPT (0.52) MEN1KMT2ARAB9AHTTSMN1; SMN2
SCHEMBL6325956 0.75 BLM (0.53) MEN1KMT2ARAB9AHTTSMN1; SMN2
SCHEMBL6323902 0.75 TRPV1 (0.41) MEN1KMT2ARAB9AHTTSMN1; SMN2
SCHEMBL6322614 0.75 TRPV1 (0.42) MEN1KMT2ARAB9AHTTSMN1; SMN2
SCHEMBL6324443 0.74 MAPT (0.54) MEN1KMT2ARAB9AHTTSMN1; SMN2
SCHEMBL6325012 0.73 RAB9A (0.55) MEN1KMT2ARAB9AHTTSMN1; SMN2
SCHEMBL6325791 0.71 BLM (0.45) MEN1KMT2ARAB9AHTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050124664-A1 Urea thiadiazole inhibitors of plasminogen activator inhibior-1 BRISTOL-MYERS SQUIBB CO. 2005-06-09 US claimed
US-20050124664-A1 Urea thiadiazole inhibitors of plasminogen activator inhibior-1 BRISTOL-MYERS SQUIBB CO. 2005-06-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050124664-A1 Urea thiadiazole inhibitors of plasminogen activator inhibior-1 SERPINE1, SERPINC1, SERPINB1 MEN1 1004/4885KMT2A 4128/4885RAB9A 3129/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.